文献速递眼整形与眼眶

骨形态发生蛋白7(BMP7)在甲状腺相关眼病发病机制中的潜在治疗作用

Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究比较了甲状腺相关眼病(GO)与正常对照眼眶组织中BMP7的表达,并在体外培养的眼眶成纤维细胞中评估重组人BMP7对TGF-β、IL-1β和TNF-α诱导的纤维化与炎症反应的影响。结果显示GO眼眶组织BMP7 mRNA表达低于对照,rhBMP7可抑制纤维化相关蛋白及促炎分子,并调节SMAD与NFκB/Akt信号通路。

要点

  • GO眼眶组织中BMP7 mRNA表达低于正常对照组织。
  • rhBMP7抑制TGF-β诱导的纤连蛋白、胶原1α及α-SMA表达。
  • rhBMP7阻断IL-1β或TNF-α诱导的IL-6、IL-8及ICAM-1增加。

核心结论

  • BMP7转录水平在GO眼眶组织中下调。
  • 外源性BMP7对眼眶成纤维细胞中促纤维化蛋白和促炎细胞因子的产生显示抑制作用,结果为BMP7作为新潜在治疗剂提供了分子基础。

研究设计与样本

  • 比较GO(n=12)与正常对照(n=12)眼眶组织外植体中BMP7表达的实时PCR研究。
  • 从GO(n=3)和正常对照(n=3)眼眶结缔组织培养眼眶成纤维细胞,经rhBMP7预处理后用TGF-β、IL-1β和TNF-α刺激,以Western blotting分析纤维化相关蛋白和炎性细胞因子。

主要发现

  • GO眼眶组织中BMP7 mRNA表达低于对照。
  • TGF-β诱导的纤维化相关蛋白纤连蛋白、胶原1α和α-SMA被rhBMP7处理抑制。
  • rhBMP7上调TGF-β诱导的SMAD1/5/8蛋白表达,而下调SMAD2/3。
  • IL-1β或TNF-α增加的促炎分子IL-6、IL-8和ICAM-1被rhBMP7处理阻断。
  • 磷酸化NFκB和Akt的表达被rhBMP7处理抑制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated a role of bone morphogenic protein 7 (BMP7), a member of the TGF-β superfamily on pathogenic mechanism of Graves' orbitopathy (GO). The therapeutic effects of BMP7 on inflammation and fibrosis were evaluated in cultured Graves' orbital fibroblasts. METHODS: Expression of BMP7 was compared in cultured orbital tissue explants from GO (n = 12) and normal control (n = 12) subjects using real-time PCR. Orbital fibroblasts were cultured from orbital connective tissues obtained from GO (n = 3) and normal control patients (n = 3). Cells were pretreated with recombinant human BMP7 (rhBMP7) before stimulation with TGF-β, IL-1β, and TNF-α. Fibrosis-related proteins and inflammatory cytokines were analyzed by Western blotting. The activation of signaling molecules in inflammation and fibrosis was also analyzed. RESULTS: The expressions of BMP7 mRNA were lower in GO orbital tissues than control. Fibrosis-related proteins, fibronectin, collagen 1α, and α-SMA induced by TGF-β were suppressed by treating rhBMP7, and rhBMP7 upregulated TGF-β induced SMAD1/5/8 protein expression, whereas downregulated SMAD2/3. Increased pro-inflammatory molecules, IL-6, IL-8, and intercellular adhesion molecule-1 (ICAM-1) by IL-1β or TNF-α were blocked by rhBMP7 treatment, and the expression of phosphorylated NFκB and Akt was suppressed by rhBMP7 treatment. CONCLUSIONS: BMP7 transcript levels were downregulated in Graves' orbital tissues. Exogenous BMP7 treatment showed inhibitory effects on the production of profibrotic proteins and proinflammatory cytokines in orbital fibroblasts. Our results provide a molecular basis of BMP7 as a new potential therapeutic agent through the opposing mechanism of profibrotic TGF-β/SMAD signaling and proinflammatory cytokine production.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kim BY, Choi SH, Kim JY, et al. Potential Therapeutic Role of Bone Morphogenic Protein 7 (BMP7) in the Pathogenesis of Graves' Orbitopathy. Invest Ophthalmol Vis Sci. 2022. PMID: 35671049. doi:10.1167/iovs.63.6.7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。